Year: 2023

Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancer

Written by Customer Service on November 7, 2023. Posted in Public Companies.

DUET-102 in Combination with PD-1 Blockade Demonstrates Significant Anti-Tumor Activity in Models of Malignant Glioma Data Suggests Benefits of Combinations of DUET-102 with Other T-Cell Based Immunotherapies, such as CAR-Ts NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) — Scopus BioPharma Inc. (OTCQB: “SCPS”) and its majority-owned subsidiary, Duet BioTherapeutics Inc., presented compelling new data that DUET-102 in combination with PD-1 blockade demonstrates significant anti-tumor activity in models of malignant glioma. The new data was presented on November 4, 2023 at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (“SITC”) by Marcin Kortylewski, Ph.D. Dr. Kortylewski, Professor of Immuno-Oncology at City of Hope, is the Co-Founder and Senior Scientific Advisor of Duet. Duet is developing novel immunotherapies to...

Capricor Therapeutics to Present Third Quarter 2023 Financial Results and Recent Corporate Update on November 14

Written by Customer Service on November 7, 2023. Posted in Public Companies.

Company to Host Conference Call, November 14, 2023, at 4:30 p.m. ET SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, will release its financial results for the third quarter ended September 30, 2023, after the market close on Tuesday, November 14, 2023. Management will then host a webcast and conference call at 4:30 p.m. ET on November 14.Title: Capricor Therapeutics Third Quarter 2023 Financial Results and Recent Corporate Update Conference Call and Webcast Date: Tuesday, November 14, 2023 Time: 4:30 p.m. ET Conference Call Details: Toll-Free: 1-888-886-7786International: 1-416-764-8658Conference...

Tejon Ranch Co. Announces Third Quarter 2023 Financial Results

Written by Customer Service on November 7, 2023. Posted in Earnings Releases And Operating Results.

TEJON RANCH, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) — Tejon Ranch Co., or the Company, (NYSE:TRC), a diversified real estate development and agribusiness company, today announced financial results for the three- and nine-months ended September 30, 2023. “The momentum we’ve built over the last several years at the Tejon Ranch Commerce Center (TRCC) continues, as the Company is experiencing increased activity,” said Gregory S. Bielli, President and CEO of Tejon Ranch Co. “A Los Angeles-based company recently pre-leased space at TRCC, and construction of our newest industrial building (MRC-5), which is also pre-leased, is on track for completion by the first quarter of 2024, adding to our portfolio of income producing assets. We continue to add new stores to the Outlets at Tejon, and later this month will be...

The Victory Bancorp, Inc., Announces 2023 Third Quarter Earnings

Written by Customer Service on November 7, 2023. Posted in Earnings Releases And Operating Results.

LIMERICK, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) — The Victory Bancorp, Inc. (OTCQX: VTYB), the holding company for The Victory Bank, announced unaudited results for the quarter ended September 30, 2023. Joseph W. Major, Bank Leader and Chief Executive Officer, stated, “Market conditions have been unusually volatile during 2023 as rates and funding costs moved sharply upwards and overall bank funding declined rapidly. The unprecedented and severe increases to interest rates have squeezed net interest income and non-interest income for most banking companies, and The Victory Bank is no exception. As a result of these external forces, the bank’s balance sheet has shrunk modestly as deposits have declined and investments have gradually run off. Expenses have remained controlled, increasing from 2.35% to 2.65%, primarily because the...

Workplace Options Acquires the Diversity Movement

Written by Customer Service on November 7, 2023. Posted in Mergers And Acquisitions.

Leading International Wellbeing Provider Acquires Employee Experience Platform Advancing Diversity, Equity, and Inclusion Initiatives Driven by Business OutcomesWorkplace Options (WPO) is the largest independent provider of bespoke wellbeing and mental health solutions for more than 79 million people in more than 200 countries and territories across the globe. On November 7, 2023, WPO announced it acquired The Diversity Movement, a technology-led consulting firm focused on diversity, equity, and inclusion (DEI). The acquisition further advances WPO’s capabilities and expertise across the full spectrum of workplace wellbeing services and will be a valuable complement to WPO’s existing holistic solutions for employees and their families. The move enables WPO to expand its global reach in helping employers build organizational...

Cassava Sciences Reports Third Quarter 2023 Financial and Operating Results

Written by Customer Service on November 7, 2023. Posted in Earnings Releases And Operating Results.

Enrollment completed for Phase 3 trials evaluating oral simufilam in Alzheimer’s. Over 1,900 patients randomized in on-going Phase 3 trials. Top-line results for 52-week Phase 3 trial expected approximately year-end 2024; top-line results for 76-week Phase 3 trial expected approximately mid-year 2025. MRI safety data suggests simufilam is not associated with ARIA. $142.4 Million in cash and cash equivalents at September 30, 2023. AUSTIN, Texas, Nov. 07, 2023 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today reported financial and operating results for the third quarter ended September 30, 2023. “In the third quarter, Cassava Sciences made important progress with simufilam, our lead drug candidate,” said Remi Barbier, President & CEO. “This progress...

YieldMax™ ETFs Announces Monthly Distributions on AMDY (65.22%), CONY (58.23%), TSLY (57.79%), DISO (42.66%), PYPY (38.82%) and Others

Written by Customer Service on November 7, 2023. Posted in Dividend Reports And Estimates.

CHICAGO, MILWAUKEE and NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) — YieldMax™ today announced monthly distributions on the following YieldMax™ Option Income Strategy ETFs:ETF Ticker1 ETF Name Reference Asset Distribution per Share Distribution Rate2 30-Day SEC Yield3 Ex-Date Record Date Payment DateTSLY YieldMax™ TSLA Option Income Strategy ETF TSLA $0.5846 57.79% 6.03% 11/8/23 11/9/23 11/16/23OARK YieldMax™ Innovation Option Income Strategy ETF ARKK $0.3837 36.73% 5.51% 11/8/23 11/9/23 11/16/23APLY YieldMax™ AAPL Option Income Strategy ETF AAPL $0.1734 10.87% 5.02% 11/8/23 11/9/23 11/16/23NVDY YieldMax™ NVDA Option Income Strategy ETF NVDA $0.4150 23.08% 4.60% 11/8/23 11/9/23 11/16/23AMZY YieldMax™ AMZN Option Income Strategy ETF AMZN $0.5439 31.50% 4.53% 11/8/23 11/9/23 11/16/23FBY YieldMax™...

Philips program developing AI-powered ultrasound to expand access to maternal health receives major funding boost

Written by Customer Service on November 7, 2023. Posted in Public Companies.

Training underway with new AI-driven ultrasound-based technology prototypeHealthcare professional using Lumify ultrasound prototype to perform a health checkInitial feedback from the trial in Kenya shows positive feedback on the new solutionNovember 7, 2023Total investment from the Bill & Melinda Gates Foundation reaches USD 60 million, accelerating expansion of new AI-guided ultrasound capabilities on Philips Lumify Handheld Ultrasound Innovation helps address worldwide shortage of healthcare workers by putting diagnostic tool previously reserved for expert technicians in the hands of midwivesAmsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received a second round of funding from the Bill & Melinda Gates Foundation to...

Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023

Written by Customer Service on November 7, 2023. Posted in Public Companies.

SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) — Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its third quarter 2023 financial results on Monday, November 13, 2023, after the market closes. The press release can be accessed via the Investor section of Telesis Bio’s website at https://ir.telesisbio.com/. About Telesis BioTelesis Bio is empowering scientists with the ability to create novel, synthetic biology-enabled solutions for many of humanity’s greatest challenges. As inventors of the industry-standard Gibson Assembly® method and the first commercial automated benchtop DNA and mRNA synthesis system, Telesis Bio is enabling rapid, accurate and reproducible writing of DNA and mRNA for numerous downstream markets. The award-winning BioXp® system consolidates,...

Advisor Anasuya Kabad Meyer’s ‘Invest in Others’ Win Garners Support for Daya, Inc.

Written by Customer Service on November 7, 2023. Posted in Public Companies.

LPL Financial challenged event attendees to boost award impact for Daya, Inc., which supports victims of domestic violence in the South Asian community SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) — LPL Financial LLC today announced that financial advisor Anasuya Kabad Meyer of Jaykay Wealth Advisors in Houston was honored as the 2023 Invest in Others Emerging Impact winner. Meyer was recognized for her work with Daya, Inc., an organization that empowers South Asian survivors of domestic and sexual violence through free and confidential culturally specific services. The award was one of four $60,000 charitable grants presented during the 2023 Invest in Others Awards program, which recognizes the charitable work of financial advisors in communities across the country and around the world. During the event, in a video message from Dan...

Year: 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals